Clinical Trial Update: Everolimus Trial in Laryngotracheal Stenosis [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial of everolimus for idiopathic subglottic tracheal stenosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Subglottic Tracheal Stenosis

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Johns Hopkins University | Conditions: Idiopathic Subglottic Tracheal Stenosis | EARLY_Phase 1 | Status: COMPLETED